These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 20591522)

  • 1. Increased levels of 8-hydroxydeoxyguanosine in the vitreous of patients with diabetic retinopathy.
    Wakabayashi Y; Usui Y; Shibauchi Y; Uchino H; Goto H
    Diabetes Res Clin Pract; 2010 Sep; 89(3):e59-61. PubMed ID: 20591522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of monokine induced by interferon-gamma (Mig) in the vitreous of patients with diabetic retinopathy.
    Wakabayashi Y; Usui Y; Okunuki Y; Takeuchi M; Kezuka T; Iwasaki T; Goto H
    Diabet Med; 2008 Jul; 25(7):875-7. PubMed ID: 18644076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased osteopontin levels in the vitreous of patients with diabetic retinopathy.
    Kase S; Yokoi M; Saito W; Furudate N; Ohgami K; Kitamura M; Kitaichi N; Yoshida K; Kase M; Ohno S; Uede T
    Ophthalmic Res; 2007; 39(3):143-7. PubMed ID: 17505146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glutamate concentration in diabetic vitreous].
    Asensio Sánchez VM; Corral Azor A; Aguirre Aragón B; De Paz García M
    Arch Soc Esp Oftalmol; 2003 Sep; 78(9):493-7. PubMed ID: 14517736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
    Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased vitreal hyaluronan levels with aging.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmologica; 2009; 223(1):32-5. PubMed ID: 18953185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy.
    Wakabayashi Y; Usui Y; Okunuki Y; Kezuka T; Takeuchi M; Goto H; Iwasaki T
    Retina; 2010 Feb; 30(2):339-44. PubMed ID: 20142713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of vitreous proteins in proliferative diabetic retinopathy.
    Kim SJ; Kim S; Park J; Lee HK; Park KS; Yu HG; Kim Y
    Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.
    Petrovic MG; Korosec P; Kosnik M; Hawlina M
    Am J Ophthalmol; 2007 Jan; 143(1):175-6. PubMed ID: 17188064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythropoietin concentrations in the vitreous body from patients with proliferative diabetic retinopathy].
    Asensio-Sánchez VM; Gómez-Ramírez V; Morales-Gómez I
    Arch Soc Esp Oftalmol; 2008 Mar; 83(3):169-72. PubMed ID: 18311675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P and secretoneurin in vitreous aspirates of patients with various vitreoretinal diseases.
    Lorenz K; Troger J; Fischer-Colbrie R; Kremser B; Schmid E; Kralinger M; Teuchner B; Bechrakis N; Kieselbach G
    Peptides; 2008 Sep; 29(9):1561-5. PubMed ID: 18550223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Roldán-Pallarés M; Rollín R; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
    Retina; 2007 Feb; 27(2):222-35. PubMed ID: 17290206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
    Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
    J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.